Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double‐blind, placebo‐controlled trial

OBJECTIVE: To evaluate the safety and efficacy of a novel formulation of midazolam administered as a single‐dose nasal spray (MDZ–NS) in the outpatient treatment of patients experiencing seizure clusters (SCs). METHODS: This was a phase III, randomized, double‐blind, placebo‐controlled trial (Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Detyniecki, Kamil, Van Ess, Peter J., Sequeira, David J., Wheless, James W., Meng, Tze‐Chiang, Pullman, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291143/
https://www.ncbi.nlm.nih.gov/pubmed/31140596
http://dx.doi.org/10.1111/epi.15159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291143/
https://www.ncbi.nlm.nih.gov/pubmed/31140596
http://dx.doi.org/10.1111/epi.15159

Ejemplares similares